1. Home
  2. PX vs PHVS Comparison

PX vs PHVS Comparison

Compare PX & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PX
  • PHVS
  • Stock Information
  • Founded
  • PX 1992
  • PHVS 2015
  • Country
  • PX United States
  • PHVS Netherlands
  • Employees
  • PX N/A
  • PHVS N/A
  • Industry
  • PX Investment Managers
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PX Finance
  • PHVS Health Care
  • Exchange
  • PX Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • PX 1.2B
  • PHVS 1.0B
  • IPO Year
  • PX 2021
  • PHVS 2021
  • Fundamental
  • Price
  • PX $13.77
  • PHVS $18.50
  • Analyst Decision
  • PX Hold
  • PHVS Strong Buy
  • Analyst Count
  • PX 9
  • PHVS 5
  • Target Price
  • PX $13.56
  • PHVS $40.60
  • AVG Volume (30 Days)
  • PX 1.0M
  • PHVS 106.8K
  • Earning Date
  • PX 11-07-2024
  • PHVS 11-13-2024
  • Dividend Yield
  • PX 1.05%
  • PHVS N/A
  • EPS Growth
  • PX N/A
  • PHVS N/A
  • EPS
  • PX 0.10
  • PHVS N/A
  • Revenue
  • PX $274,501,000.00
  • PHVS N/A
  • Revenue This Year
  • PX $20.64
  • PHVS N/A
  • Revenue Next Year
  • PX $5.44
  • PHVS N/A
  • P/E Ratio
  • PX $133.68
  • PHVS N/A
  • Revenue Growth
  • PX 15.82
  • PHVS N/A
  • 52 Week Low
  • PX $7.08
  • PHVS $15.37
  • 52 Week High
  • PX $14.28
  • PHVS $33.00
  • Technical
  • Relative Strength Index (RSI)
  • PX 61.28
  • PHVS 40.29
  • Support Level
  • PX $12.78
  • PHVS $17.93
  • Resistance Level
  • PX $13.75
  • PHVS $20.17
  • Average True Range (ATR)
  • PX 0.37
  • PHVS 1.53
  • MACD
  • PX -0.11
  • PHVS -0.15
  • Stochastic Oscillator
  • PX 55.34
  • PHVS 14.38

About PX P10 Inc.

P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

Share on Social Networks: